Recent Insider Transactions - Neurocrine Biosciences (NASDAQ: NBIX)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

12/17/2024

Buy

$136.69

27,770

$3.796M

27,770

NASDAQ NBIX Neurocrine Biosciences

Delaet Ingrid / officer: Chief Regulatory Officer

12/17/2024

Buy

$79.02

1,091

$86K

3,598

NASDAQ NBIX Neurocrine Biosciences

Delaet Ingrid / officer: Chief Regulatory Officer

12/17/2024

Sell

$79.02

1,091

$86K

2,990

NASDAQ NBIX Neurocrine Biosciences

Delaet Ingrid / officer: Chief Regulatory Officer

12/17/2024

Sell

$135.00

1,091

$147K

2,507

NASDAQ NBIX Neurocrine Biosciences

Onyia Jude / officer: Chief Scientific Officer

11/29/2024

Sell

$126.29

2,331

$294K

15,449

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

11/08/2024

Buy

$79.02

$79

31,061

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

11/08/2024

Buy

$102.90

971

$100K

31,060

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

11/08/2024

Buy

$81.05

1,233

$100K

30,089

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

11/08/2024

Buy

$77.81

5,140

$400K

28,856

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

11/08/2024

Sell

$79.02

$79

1,265

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

11/08/2024

Sell

$77.81

5,140

$400K

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

11/08/2024

Sell

$81.05

1,233

$100K

NASDAQ NBIX Neurocrine Biosciences

ROBERTS EIRY / officer: Chief Medical Officer

11/08/2024

Sell

$102.90

971

$100K

NASDAQ NBIX Neurocrine Biosciences

Gano Kyle / director, officer: Chief Executive Officer

11/01/2024

Buy

$122.21

13,344

$1.631M

13,344